Open access · CC-BY
via OpenAlex
Mesenchymal stem cells: An efficient cell therapy for tendon repair (Review)
Li Jiang, Jingwei Lu, Yixuan Chen, Kexin Lyu, Longhai Long, Xiaoqiang Wang, Tianzhu Liu, Sen Li
International Journal of Molecular Medicine · 2023 · ▲ 55 citations
Stem-cell exhaustion
Altered intercellular communication
Chronic inflammation
Stem-cell therapy
Partial reprogramming (OSK)
Cell culture / in vitro
Human
Preclinical / animal
In vitro
Review
Abstract
Tendon injury is a common disorder of the musculoskeletal system caused by overuse or trauma. With increasing incidence of tendon injuries, it is necessary to find an effective treatment. Mesenchymal stem cells (MSCs) are attracting attention because of their high proliferative and self‑renewal capacity. These functions of MSCs show promise in treating a variety of diseases, including immune and musculoskeletal system disorder and cardiovascular disease, and show especially satisfactory effects in the treatment of tendon injury. First, since MSCs have multidirectional differentiation potential, they differentiate into specific cells after induction in vivo and in vitro. Furthermore, MSCs have paracrine functions and can secrete biologically active molecules and exosomes such as cytokines, growth factors and chemokines to promote tissue repair and regeneration. In tendon injury, MSCs promote tendon repair through four mechanisms: Decreasing inflammation and promoting neovascularization and cell proliferation and differentiation. They are also involved in extracellular matrix reorganization by promoting collagen production and transforming type III collagen fibers to type I collagen fibers. The present review summarized preclinical experiments with different sources of MSCs and their mechanisms in tendon repair, as well as the limitations of MSCs in current clinical applications and directions that need to be explored in the future.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3892/ijmm.2023.5273
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Jiang, L., Lu, J., Chen, Y., Lyu, K., Long, L., Wang, X., Liu, T., & Li, S. (2023). Mesenchymal stem cells: An efficient cell therapy for tendon repair (Review). <em>International Journal of Molecular Medicine</em>. https://doi.org/10.3892/ijmm.2023.5273
Vancouver
Jiang L, Lu J, Chen Y, Lyu K, Long L, Wang X, et al. Mesenchymal stem cells: An efficient cell therapy for tendon repair (Review). International Journal of Molecular Medicine. 2023. doi:10.3892/ijmm.2023.5273.
BibTeX
@article{li2023Mesenc,
title = {Mesenchymal stem cells: An efficient cell therapy for tendon repair (Review)},
author = {Li Jiang and Jingwei Lu and Yixuan Chen and Kexin Lyu and Longhai Long and Xiaoqiang Wang and Tianzhu Liu and Sen Li},
journal = {International Journal of Molecular Medicine},
year = {2023},
doi = {10.3892/ijmm.2023.5273},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Bulletin Biomedicine and sociology 2024
Citation only
MESENCHYMAL STEM CELLS AND FIBROBLASTS IN AGE-RELATED REMODELING OF THE MUSCULOSKELETAL SYSTEM
Advanced Pharmaceutical Bulletin 2015
Open access · CC-BY
The Effect of Hypoxia on Mesenchymal Stem Cell Biology
World Journal of Experimental Medicine 2024
Open access · CC-BY
Anti-aging based on stem cell therapy: A scoping review
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY
The secretion profile of mesenchymal stem cells and potential applications in treating human diseases
Arthritis Research & Therapy 2007
Open access · OA
Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation.
Science 2023
Preprint · OA